Divalproex Sodium
Product Images NDC 71610-311

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71610-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 500 mg (71610 0311 53)

Label for Divalproex Sodium ER, USP 500 mg tablets. The package contains 60 tablets. The label includes storage instructions to store between 20-25 degrees Celsius and to keep out of reach of children. It indicates the product is for RX only and is labeled by Aphena Pharma Solutions - Tennessee, LLC, with manufacturing noted in Ahmedabad, India.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

10 (Divalproex Sodium Extended Release Tablets Usp 1)

Chemical structure of Divalproex Sodium depicting its molecular arrangement with sodium ion (Na+) and associated organic groups, illustrating the compound's composition.*

FDA Label Image

Figure 1 (Divalproex Sodium Extended Release Tablets Usp 2)

A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium and placebo across the percentage of patients. The graph shows improvement and worsening on the vertical axis, with Divalproex Sodium represented by a solid line and placebo by a dashed line.*

FDA Label Image

Figure 2 (Divalproex Sodium Extended Release Tablets Usp 3)

A cumulative distribution plot comparing high dose and low dose Divalproex Sodium on the percent reduction in CPS rate versus percent of patients. The y-axis represents percentage reduction with positive values indicating improvement and negative values indicating worsening. Two lines show outcome differences between high dose (solid line) and low dose (dashed line) Divalproex Sodium treatment groups.*

FDA Label Image

Figure 3 (Divalproex Sodium Extended Release Tablets Usp 4)

A bar graph comparing values for Placebo and Divalproex Sodium Extended Release. The y-axis ranges from 0 to 1.2, showing the Placebo bar at 0.6 and the Divalproex Sodium Extended Release bar at 1.2, with a significance marker (p=0.006) noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.